3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Breast Neoplasms
4
Ovarian Neoplasms
3
Triple Negative Breast Neoplasms
2
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Overweight
2
Obesity
2
Multiple Myeloma
2
Motor Activity
2
Melanoma
2
Lung Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Weight Loss
1
Uveal Melanoma
1
Smoking Cessation
1
Quality of Life
1
Postoperative Complications
1
Patient Compliance
1
Neoplasms
1
Metabolic Syndrome
1
Localized Prostate Carcinoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Insulin Resistance
1
Inflammation
1
Hypothalamic Neoplasms
1
Healthy Diet
1
Glioma
1
Gastrointestinal Neoplasms
1
Interventions
pembrolizumab
45
Paclitaxel
42
Carboplatin
34
Bevacizumab
18
Specimen Handling
17
Letrozole
16
lenvatinib
13
Magnetic Resonance Spectroscopy
12
dostarlimab
11
Cisplatin
11
Biopsy
11
Taxes
10
olaparib
9
Fulvestrant
9
Doxorubicin
9
abemaciclib
8
Megestrol Acetate
8
Docetaxel
8
durvalumab
7
atezolizumab
7
Nivolumab
7
Gemcitabine
7
Blood Specimen Collection
7
palbociclib
6
Oxaliplatin
6
Observation
6
Fluorouracil
6
niraparib
5
Surveys and Questionnaires
5
Progestins
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Diet Therapy
×
1 year
×
Clear all
No trials found.